Last updated on June 2018

A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy


Contact Investigators or Research Sites near you

Start Over

Jeannine Madere

Lake Success, NY United States